Regeneron Pharmaceuticals (REGN) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist

706.940
-16.530-2.28%

Close Feb 26 16:00 ET

707.000
+0.060+0.01%

Pre 04:01 ET

77.29BMarket Cap18.44P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Wall Street Today: Market Quaking With Anticipation, and Nvidia Delivers Beat
Kevin Travers16:57 ET
Live Stock News: Market Climbs Back From Tech Pit, Awaits Prodigal Semi Son to Report
Kevin Travers11:15 ET
Regeneron: FDA Accepts Odronextamab Lymphoma Drug Resubmission
WSJFeb 26 07:43 ET
Express News | Regeneron Pharmaceuticals Inc - FDA Decision on Odronextamab Expected by July 30, 2025
ReutersFeb 26 07:15 ET
Express News | Odronextamab Bla Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma
ReutersFeb 26 07:00 ET
Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma
GlobeNewswireFeb 26 07:00 ET

Comments

Teddy123

22 hours ago

Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma

$Regeneron Pharmaceuticals (REGN.US)$
Can Regeneron's Cancer Drug With 80% Response Rate Secure FDA Approval For Lymphoma?

$Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma$

Teddy123

Feb 25 00:11

Latest DB-OTO Results Demonstrate Clinically Meaningful Hearing Improvements in Nearly All Children with Profound Genetic Hearing Loss in CHORD Trial

$Regeneron Pharmaceuticals (REGN.US)$
Revolutionary Hearing Breakthrough: Can This Gene Therapy End Childhood Genetic Deafness?

TRIUMPHANT RETURNS

Feb 18 16:38

LOTS OF NOTABLE NAMES IN THIS STOCK!

$Novo-Nordisk A/S (NVO.US)$ $Moderna (MRNA.US)$ $Johnson & Johnson (JNJ.US)$ $Netflix (NFLX.US)$ $Uber Technologies (UBER.US)$ $Grab Holdings (GRAB.US)$ $ParkwayLife Reit (C2PU.SG)$ $Tempus AI (TEM.US)$ $Serve Robotics (SERV.US)$ $Tesla (TSLA.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $Amgen (AMGN.US)$

Share Your Profit/Loss

韭菜变主力

Feb 4 10:54

$Regeneron Pharmaceuticals (REGN.US)$ In traditional technical analysis, you would think this is likely reversed given the engulfing pattern with strong volume at an earnings event. But in this trending market, a higher high has to be established.

10xStockPicks

Jan 23 07:47

Today 3 Analysts Place BUY Ratings On This $2 Stock $7,$9 & $16 Which Is An Acquisition Target by BIG Pharma

$Esperion Therapeutics (ESPR.US)$ Jan 23, 2025 Three analysts are bullish on Esperion Therapeutics with price targets on this $2 stock ranging from $7 to $16 a share.
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...

REGN Regeneron Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Trending Stocks